Approved Studies sorted on Review Date

ACTIVE STUDY: Bioidentical Hormone Replacement Therapy and Cardiovascular Function

Approval Status: Approved
Number: 30
Submission Date April 27, 2022
Is this study IRB-Approved? Yes
Date of NEXT IRB Review: 02/20/2023
Full Study Name: Bioidentical Hormone Replacement Therapy and Cardiovascular Function
Short Study Name: Hormones and Women’s Heart Health
College / Affiliation College of Health Sciences
Relevant Research Categories Cardiovascular (Heart and Circulation), Healthy Volunteers, Women’s Health
Location of Study: University of Delaware STAR Campus, 540 S College Ave, Newark, DE 19713
Description of Study:

The Women’s Cardiovascular Research Lab is recruiting perimenopausal and postmenopausal women ages 40-70 to understand how bioidentical hormone replacement therapy affects cardiovascular function. To do this, we will use
several techniques including measures of blood pressure, heart rate, and blood vessel function. We are looking to recruit both women taking this hormone therapy and those not taking this hormone therapy. This study will require a virtual screening and consent and 4 in-person visits for a total of approximately 4.5 hours. Participants will receive $100 compensation.

Will participants be compensated for participation?
Inclusion and Exclusion Criteria:

You are eligible for this study if you are a healthy peri- or postmenopausal woman between the ages of 40-70. You will not be able to participate if you have a BMI greater than 35, use tobacco products, are pregnant, planning on becoming pregnant, or are breast feeding, have a history of blood clots, pulmonary embolism, deep vein thrombosis, stroke, liver disease, hypertension, diabetes, epilepsy, or gallbladder disease, are using blood pressure or heart medications, have a history of breast cancer, abnormal vaginal bleeding not related to period, fibroids in the uterus, or have had an abnormal gynecological exam with the last year, or have used hormonal IUDs, oral contraceptives or other forms of hormone replacement therapy within the last 3 months.

“How to Apply” Description:

If you would like more information or would like to participate, please contact Ally Schwab via email (

How to Apply Link:
How to Apply Email:
Contact Name: Allyson
Contact Last Wenner
Contact Email:
Phone: 6039333216
PI Name: Megan
PI Last Wenner
PI Email: